In 2021, the market for Biopsy Devices worldwide was worth $ 2.45 billion US dollars. AMR Group projects that the market will reach US$ 4.34 billion by 2031, growing at a CAGR of 7.28 percent between 2022 and 2031.
Industry Overview
A medical technique called a biopsy allows doctors to examine and expel malignant tissue from the body. The test is used to collect tissue samples for disease diagnosis when a patient is suspected of having cancer. Skin biopsies, vacuum biopsies, incision and excision biopsies, needle biopsies, small needle aspirations, and shave biopsies are all used to diagnose cancer.
Generally, malignant and inflammatory disorders are the focus of biopsies, which include the surgical removal of tissue from an organ to ascertain the existence or severity of a disease. Radiologists, interventional cardiologists, and surgeons typically conduct it. As a confirmatory test for cancer and celiac disease, biopsies can be carried out on any organ using specialized biopsy equipment. Each biopsy tool has a different use depending on the type of organ being studied. Advanced imaging technologies, such as MRI-guided biopsy, stereotactic-guided biopsy, ultrasound-guided biopsy, CT scan, and others, can be used in conjunction with conventional biopsy instruments to perform biopsy with accuracy and less invasiveness. The lungs, liver, and kidneys are just a few of the bodily organs whose biopsies are carried out using these integrated techniques.
The prevalence of various cancer forms has considerably grown over time. In 2020, cancer will be responsible for about 10 million deaths worldwide. Globally increasing rates of various malignancies are also raising knowledge of the availability of diagnostic and screening technologies and driving up demand for efficient treatment.
Market Dynamics
One of the factors fueling the market's expansion is the burden of the prevalence of different cancers, including as breast cancer, lung cancer, and other forms of cancer, is anticipated to increase the market's overall growth. For instance, the American Cancer Society projects that 1.9 million new instances of cancer will be discovered in the United States in 2022. The improvement of sophisticated biopsy techniques is being aided by the increased prevalence of cancer.
The appeal of minimally invasive medical treatments is increased by the fact that they have a number of benefits. Patients recover more quickly from such operations, which are also less stressful. Manufacturer-published research findings indicate that minimally invasive procedures are quickly replacing invasive procedures and delivering greater patient satisfaction levels. Growing consumer demand for minimally invasive procedures and disposable biopsy tools is expected to fuel business expansion. Technology-advanced biopsy guiding devices, such vacuum-assisted guns, are becoming more and more well-liked among patients and medical professionals. It is projected that the market would continue to expand as a result of the senior population's expanding base and the development of affordable, cutting-edge gadgets. However, the high cost associated with Biopsy Devices is a restraining factor in the global Biopsy Devices market
COVID Impact
The COVID-19 pandemic gave a negative impact on the Biopsy Devices business market. The development of COVID-19 had a negative influence on the healthcare sector. The market for biopsy instruments was also severely impacted, therefore it is not a spectator sport. The government implemented lockdown and social segregation measures to contain the COVID-19 pandemic outbreak. These measures caused a number of problems, including the suspension of several manufacturing operations, disruptions in the supply chain, stifling business growth, cancellations of technology treatments, and even an impact on overall production and sales, which restricted the industry's growth. Also, the healthcare industry gave priority to the relevance of routine surgical procedures and if possible, explored non-surgical therapeutic methods. Market expansion was hampered by the rise of non-surgical procedures and the avoidance of surgical procedures.
Regional Trend
Geographically, in 2022, North America had a significant revenue share of over 40.0%. It will continue to hold a sizable part of the market during the projection period because of the established industry players based there. The regional market is anticipated to benefit from high market penetration rates of technologically sophisticated equipment like vacuum-assisted biopsy systems and a quickly rising disposable device demand. The majority of biopsies are performed in the United States. For instance, 3 million breast biopsies are carried out in the U.S. each year, according to a research report titled "The Breast" that was released in 2018. Additionally, because medical devices are regarded as having a moderate level of risk, the U.S. FDA has a less strict regulatory approval procedure.
The Asia Pacific region offers fantastic potential for business expansion. The region's market is expected to rise as a result of the rapidly evolving healthcare infrastructure in developing Asia-Pacific nations, the high level of unmet patient demands, and the rising prevalence of cancer. According to Global Cancer Statistics 2020, Asia is projected to account for 58.3% of cancer deaths and 50% of all cancer cases. Moreover, changes implemented in China and India are anticipated to boost the purchasing power of healthcare organizations, consequently accelerating sector growth.
Competitive Landscape
Key players operating in the Biopsy Devices Market includes, Argon Medical Devices Inc., B. Braun Melsungen AG, BD, Boston Scientific Corporation, Cardinal Health Inc., CONMED Corporation, Cook Medical, Danaher Corporation, Devicor Medical Products Inc., DTR Medical, FUJIFILM Holdings Corporation, Gallini Srl, Hologic, Inc., INRAD, Inc., Leica Biosystems Nussloch GmbH, Medtronic, Olympus Corporation and TransMed7, LLC among others. A well-known manufacturer of medical equipment used in interventional radiology and interventional oncology procedures, IZI Medical Products LLC ("IZI"), introduced The Quick-Core Auto Biopsy System ("Quick-Core Auto") for soft tissue biopsy in March 2021. The Quick-Core Auto is a portable, fully automatic biopsy device that enhances the Quick-Core semi-automatic biopsy system from IZI in terms of dependability, accuracy, and quality.
Key USPs-
A partnership between Biocept, Inc. and Quest Diagnostics (NYSE: DGX) to provide laboratory testing services for the Target SelectorTM NGS-based liquid biopsy targeted lung cancer panel to Quest patients was announced in June 2021. Quest Diagnostics is a leading provider of molecular diagnostic assays, products, and services. The leading provider of diagnostic information services, including complex diagnostics, is Quest Diagnostics.
Market Segmentation
Based upon the Product in the Biopsy Devices market is segmented Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires, and Other Products. The Product segment is dominated in 2022 by needle-based biopsy guns held the majority share of more than 40.0%. Throughout the forecast period, a surge in demand for these guns to get samples from internal organs' soft tissues, including the kidneys, breasts, and lungs, is anticipated to support the market's expansion overall. Based on the Guidance Technique, the Biopsy Devices market is segmented into Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, MRI-Guided Biopsy and Other Guidance Techniques. The Guidance Technique segment is dominated in 2022 by Ultrasound-Guided Biopsy held the majority share. Based on the Application, the Biopsy Devices market is segmented into Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy and Other Applications. The Application segment is dominated in 2022 by Breast Biopsy held the majority share.
End user segment of Biopsy Devices market is further bifurcated into Hospitals, Academic & Research Institutes, and Diagnostic & Imaging Centers. In 2021, the Diagnostic & Imaging Centers segment held the biggest market share. Demand for the category is rising as more cancer infected people were being diagnosed.
By Product
· Needle-Based Biopsy Instruments
· Procedure Trays
· Localization Wires
· Other Products
By Guidance Technique
· Ultrasound-Guided Biopsy
· Stereotactic-Guided Biopsy
· MRI-Guided Biopsy
· Other Guidance Techniques
By Application
· Breast Biopsy
· Lung Biopsy
· Colorectal Biopsy
· Prostate Biopsy
· Other Applications
By End User
· Hospitals
· Academic and Research Institutes
· Diagnostic and Imaging Centers
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
Only Three Thousand Nine Hundred Fifty US dollar
Only Four Thousand Nine Hundred Fifty US dollar
Only Five Thousand Nine Hundred Fifty US dollar